Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Magn Reson Imaging. 2018 Feb 13;48(2):459–468. doi: 10.1002/jmri.25977

Table 2.

Summary of Ktrans and Ve measured in different patient subgroups. Among all lesions, the Ktrans in inflammation was significantly higher than those in malignant lesions (P=0.020). Ve was also higher in inflammation compared to malignant lesions without statistical significance (P=0.177). The Ktrans in malignant lesions was significantly higher than those in benign lesions (pneumoconiosis and tuberculoma) (P=0.001). The Ve was higher in malignant lesions compared to benign lesions without statistical significance (P=0.063).

(−): standard deviation not applicable.

Group No. of patients (%) Mean Ktrans Mean Ve
Malignant lesions 17 (73.9) 0.37±0.22 0.26±0.12
 Adenocarcinoma 10 (43.5) 0.41±0.28 0.29±0.14
 Squamous cell carcinoma 5 (21.7) 0.33±0.07 0.24±0.06
 Small cell lung cancer 1 (4.3) 0.24(−) 0.18(−)
 Non-small cell carcinoma 1 (4.3) 0.30(−) 0.16(−)
Benign lesions 2 (8.7) 0.07±0.01 0.10±0.00
 Pneumoconiosis 1 (4.3) 0.07(−) 0.10(−)
 Tuberculoma 1 (4.3) 0.06(−) 0.10(−)
Inflammation 4 (17.4) 0.78±0.52 0.36±0.16